Approval · Notice of Compliance 12182 · 2011
SUMMIT ULTRA: Notice of Compliance 12182
Issued March 18, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12182
- Date
- March 18, 2011
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Product name change
- Therapeutic class
- Muscle relaxant / Analgesic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SUMMIT ULTRA | 02360357 | Dormant |
Medicinal ingredients
- METHOCARBAMOL 500 MG per TAB
- IBUPROFEN 400 MG per TAB